Protagenic Therapeutics, Inc.\new Increase (Decrease) in Derivative Liabilities
Protagenic Therapeutics, Inc.\new (PTIX) reported Increase (Decrease) in Derivative Liabilities of -$1.51 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-08-14
- Protagenic Therapeutics, Inc.\new increase (decrease) in derivative liabilities for the quarter ending 2026-03-31 was -$326.07K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was -$3.11M.
- Protagenic Therapeutics, Inc.\new increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was -$203.35K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in derivative liabilities for the quarter ending 2025-06-30 was $2.13M.
- Protagenic Therapeutics, Inc.\new increase (decrease) in derivative liabilities for fiscal 2026 was -$1.51M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$326.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | -$3.44M derived: sum of 2 quarters · filed 2026-08-14 | -$3.64M derived: sum of 3 quarters · filed 2026-08-14 | -$1.51M 10-K · filed 2026-08-14 |
| 2025-12-31 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | -$3.32M derived: sum of 2 quarters · filed 2026-03-09 | -$1.18M 10-Q · filed 2026-03-09 | |
| 2025-09-30 | -$203.35K derived: 10-Q 6 month − 10-QT 3 month · filed 2025-11-26 | $1.93M 10-Q · filed 2025-11-26 | ||
| 2025-06-30 | $2.13M 10-QT · filed 2025-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |